Comparison of Nebulized Fentanyl, Midazolam and Dexmedetomidine as a Premedication in Pediatric Dental Surgeries

Sponsor
Zagazig University (Other)
Overall Status
Completed
CT.gov ID
NCT04226885
Collaborator
(none)
39
1
3
25.7
1.5

Study Details

Study Description

Brief Summary

  • The preoperative time can be traumatic for young children undergoing surgery. Pediatric anesthesiologists act strongly to decrease distress for children in the operating room (OR) and to provide a smooth induction of anesthesia.

  • Many drugs have been used as premedication to decrease anxiety , facilitate smooth induction and easy separation of children from their parents.

  • This study was designed to evaluate and compare the effect and safety of nebulized either fentanyl, midazolam or nebulized dexmedetomidine as a sedative premedication prior to general anesthesia (GA) in outpatient pediatric dental surgeries.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

The preoperative time can be traumatic for young children undergoing surgery. Pediatric anesthesiologists act strongly to decrease distress for children in the operating room (OR) and to provide a smooth induction of anesthesia(1). Parentral separation and needle injection increase preoperative anxiety. Preoperative stress response stimulates the sympathetic, parasympathetic, and endocrine systems, leading to an increase in heart rate (HR), blood pressure, and cardiac excitability(2,3) . Dental procedures are assiociated by high rate of fear and anxiety in children (4).

Many drugs have been used as premedication to decrease anxiety , facilitate smooth induction and easy separation of children from their parents. The ideal premedication especially in children must be acceptable with rapid onset ,minimal side effects and with rapid postoperative recovery and return to alertness (5,6).

Fentanyl is a potent analgesic opioid with a rapid onset, and short duration of action (7). Midazolam is a short-acting benzodiazepine that has anxiolytic, amnestic, hypnotic, anticonvulsant and muscle relaxant actions (8,9). Dexmedetomidine is a selective α-2 adrenergic agonist that has both sedative and analgesic effects (10-12)

Preoperative sedation in children is usually administered via the rectal, oral sublingual, and intranasal routes with different degrees of patient acceptance.(13-18). Nebulized drug is an alternative method of sedation that is relatively easy to set up, without need for venipuncture, and is associated with high bioavailability of the drug (19,20).

This study was designed to evaluate and compare the effect and safety of nebulized either fentanyl, midazolam or nebulized dexmedetomidine as a sedative premedication prior to general anesthesia (GA) in outpatient pediatric dental surgeries. The primary end point is the time of sedation and level of sedation when the child is first seen in the operating room(OR) 30 minutes after using studied drugs, based on the Modified Observer's Assessment of Alertness/Sedation Scale(19). The secondary end points are parentral separation, tolerance to mask induction, reaction to intravenous cannulation, hemodynamic changes( systolic blood pressure, diastolic blood pressure and heart rate), sedation at emergence and wake-up behavior.

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Nebulized Fentanyl, Midazolam and Dexmedetomidine as a Sedative Premedication in Outpatient Pediatric Dental Surgeries : A Randomized Double Blind Study.
Actual Study Start Date :
Mar 1, 2019
Actual Primary Completion Date :
Jan 20, 2021
Actual Study Completion Date :
Apr 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: fentanyl

patients will be given nebulized fentanyl 2μg/kg body weight 30 min before surgery

Drug: fentanyl
nebulized fentanyl 2μg/kg body weigh
Other Names:
  • fentanyl,
  • Active Comparator: midazolam

    The patients will be given nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.

    Drug: midazolam
    nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.
    Other Names:
  • dormicum
  • Active Comparator: dexmedetomidine

    The patients will be given nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.

    Drug: dexmedetomidine
    nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.
    Other Names:
  • precedex
  • Outcome Measures

    Primary Outcome Measures

    1. of onset of sedation [Baseline (before surgery)]

      onset of sedation based on the Modified Observer's Assessment of Alertness/Sedation Scale 6Appears alert and awake, responds readily to name spoken in normal tone 5 Appears asleep but responds readily to name spoken in normal tone 4 Lethargic response to name spoken in normal tone 3 Responds only after name is called loudly or repeatedly 2 Responds only after mild prodding or shaking 1 Does not respond to mild prodding or shaking 0 Does not respond to noxious stimulus

    Secondary Outcome Measures

    1. Heart rate [Baseline (before surgery) and intraoperative]

      hemodynamic changes

    2. systolic and diastolic blood pressure [Baseline (before surgery) and intraoperative]

      hemodynamic changes

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 6 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Parent acceptance.Children 2-6 years old of either sex.12-18 kg body weight. american society of anesthesiologist I-II.outpatients dental surgeries under general anesthesia.
    Exclusion Criteria:

    Difficult airway .central nervous system dysfunction.Advanced Cardiovascular ,liver, renal diseases. Allergy to the drugs under study. Patients with any intranasal pathology or congenital anomaly.Patient refusal to take the inhaled premeditation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Medicine,Zagazig University Zagazig Zagazig, Elsharkia,egypt Egypt 44519

    Sponsors and Collaborators

    • Zagazig University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marwa Mohamed Medhat, lecture of anesthesia and surgical intensive care, Zagazig University
    ClinicalTrials.gov Identifier:
    NCT04226885
    Other Study ID Numbers:
    • 5742-3-12-2019
    First Posted:
    Jan 13, 2020
    Last Update Posted:
    Apr 21, 2021
    Last Verified:
    Apr 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Marwa Mohamed Medhat, lecture of anesthesia and surgical intensive care, Zagazig University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 21, 2021